Protease inhibitor approved for AIDS treatment.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D017320:HIV Protease Inhibitors; D019469:Indinavir